Annual Net Margin
-792.75%
-45.04%-6.02%
December 31, 2024
Summary
- As of March 13, 2025, RXRX annual net profit margin is -792.75%, with the most recent change of -45.04% (-6.02%) on December 31, 2024.
- During the last 3 years, RXRX annual net margin has risen by +1072.04% (+57.49%).
- RXRX annual net margin is now -31.36% below its all-time high of -603.50%, reached on December 31, 2022.
Performance
RXRX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-3965.99%
-3598.53%-979.30%
December 31, 2024
Summary
- As of March 13, 2025, RXRX quarterly net profit margin is -3965.99%, with the most recent change of -3598.53% (-979.30%) on December 31, 2024.
- Over the past year, RXRX quarterly net margin has dropped by -3598.53% (-979.30%).
- RXRX quarterly net margin is now -979.30% below its all-time high of -367.46%, reached on September 30, 2024.
Performance
RXRX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
RXRX Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.0% | -979.3% |
| 3 y3 years | +57.5% | -979.3% |
| 5 y5 years | +78.1% | -979.3% |
RXRX Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.4% | +57.5% | -979.3% | at low |
| 5 y | 5-year | -31.4% | +78.1% | -979.3% | at low |
| alltime | all time | -31.4% | +78.1% | -979.3% | at low |
Recursion Pharmaceuticals Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -792.75%(+6.0%) | -3965.99%(+979.3%) |
| Sep 2024 | - | -367.46%(-45.7%) |
| Jun 2024 | - | -677.17%(-0.0%) |
| Mar 2024 | - | -677.29%(-22.6%) |
| Dec 2023 | -747.71%(+23.9%) | -875.34%(-4.9%) |
| Sep 2023 | - | -920.78%(+32.2%) |
| Jun 2023 | - | -696.50%(+29.4%) |
| Mar 2023 | - | -538.38%(+28.1%) |
| Dec 2022 | -603.50% | -420.39%(-9.2%) |
| Sep 2022 | - | -463.07%(-45.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -856.66%(-18.9%) |
| Mar 2022 | - | -1056.41%(-59.3%) |
| Dec 2021 | -1864.79%(-26.8%) | -2597.32%(+36.9%) |
| Sep 2021 | - | -1897.12%(+9.3%) |
| Jun 2021 | - | -1736.04%(+41.3%) |
| Mar 2021 | - | -1228.68%(+21.6%) |
| Dec 2020 | -2549.25%(-29.5%) | - |
| Dec 2020 | - | -1010.04%(-63.5%) |
| Sep 2020 | - | -2769.49% |
| Dec 2019 | -3616.54% | - |
FAQ
- What is Recursion Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual net margin year-on-year change?
- What is Recursion Pharmaceuticals quarterly net profit margin?
- What is the all time high quarterly net margin for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly net margin year-on-year change?
What is Recursion Pharmaceuticals annual net profit margin?
The current annual net margin of RXRX is -792.75%
What is the all time high annual net margin for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual net profit margin is -603.50%
What is Recursion Pharmaceuticals annual net margin year-on-year change?
Over the past year, RXRX annual net profit margin has changed by -45.04% (-6.02%)
What is Recursion Pharmaceuticals quarterly net profit margin?
The current quarterly net margin of RXRX is -3965.99%
What is the all time high quarterly net margin for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly net profit margin is -367.46%
What is Recursion Pharmaceuticals quarterly net margin year-on-year change?
Over the past year, RXRX quarterly net profit margin has changed by -3598.53% (-979.30%)